Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.33 | N/A |
| PEG Ratio (TTM) | 0.70 | N/A |
| P/S Ratio (TTM) | 1.61 | N/A |
| P/B Ratio (TTM) | 0.89 | N/A |
| P/FCF Ratio (TTM) | 37.17 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.35 | N/A |
| Price to 5YR AVG FCF Ratio | 9.25 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.63% | N/A |
| ROE (TTM) | 7.61% | N/A |
| Net Profit Margin (TTM) | 13.06% | N/A |
| ROIC 5YR AVG | 6.61% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 20.37% | -14.88% | 52.57% |
| Revenue | 12.57% | 16.10% | 7.51% |
| Net Income | 19.77% | -12.05% | 51.38% |
| Cash Flow | 514.29% | 32.45% | 17.29% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.34 | N/A |
| Quick Ratio (TTM) | 0.34 | N/A |
| D/E Ratio (TTM) | 0.89 | N/A |
| Interest Coverage (TTM) | -0.23 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 12.26 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.57% | N/A |